Static Chart OKYO Pharma Limited

Equities

Delayed Nasdaq Other stock markets 16:31:16 17/06/2024 BST			5-day change	1st Jan Change
1.3 ^USD	-0.62%		-4.33%	-26.55%

03-22	H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating	MT
03-22	OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101	CI

Duration

Period